Edwards Lifesciences logo

EWEdwards Lifesciences

Pharma & Healthcare · US · Edwards Lifesciences Corporation

6 of 6 ratios computed · receipts verified server-side

Idiot Index
37
out of 100 · 6/6 ratios · FY 2023

The full receipt

Latest published value for each ratio, with the sector median for context and year-over-year change where the prior year is available.

  • Markup

    How much revenue per dollar of cost.

    4.1897× revenue / costverified
    $1 of cost becomes $4.19 of revenue
    Sector median: 3.1882Top 21% for extraction in sector
    FY 2023v1.0.0
  • Operational Markup

    Revenue per dollar of cost + operating expenses. The multiplier after legitimate operations.

    1.4353× revenue / (cost + opex)verified
    $1 of cost+opex becomes $1.44 of revenue
    Sector median: 1.2871Top 20% for extraction in sector
    FY 2023v1.0.0
  • Labor Share

    How much of every revenue dollar reaches workers.

    0.2269of revenue → workersapprox.verified
    23¢ of every $1 of revenue reaches workers
    Sector median: 0.1761Median range for extraction in sector
    FY 2023v1.0.0
  • Executive Extraction

    How many times a CEO out-earns the median employee.

    264.7× CEO / median workerverified
    CEO earns 265× the median worker
    Sector median: 263.0Median range for extraction in sector
    FY 2023v1.0.0
  • Shareholder Extraction

    Dollars sent to shareholders for every dollar invested in R&D.

    0.5678× buybacks+dividends / R&Dverified
    $0.57 to shareholders per $1 in R&D — net reinvesting
    Sector median: 0.7492Median range for extraction in sector
    FY 2023v1.0.0
  • Capital Extraction

    How much of net profit goes to shareholders rather than back into the business.

    0.3412× buybacks+dividends / net incomeverified
    34% of net profit returned to shareholders, 66% reinvested
    Sector median: 0.5294Median range for extraction in sector
    FY 2023v1.0.0

Company response

No verified response yet. If you represent Edwards Lifesciences, you can add context, agree, or dispute.

Source data

Every raw line item this company disclosed in its XBRL filings. Click any filing to view the original on SEC.gov.

FY 2023· 9 facts
ConceptValueUnitPeriodFilingReceipt
CEO Total Compensation
CEOTotalCompensation
13,333,852USDFY0001099800-24-000032verified
Cost of Goods Sold
CostOfGoodsAndServicesSold
1,248,900,000USDFY0001099800-24-000004verified
Median Employee Compensation
MedianEmployeeCompensation
50,368USDFY0001099800-24-000032verified
Net Income
NetIncomeLoss
1,503,100,000USDFY0001099800-24-000004verified
Operating Expenses
OperatingExpensesDerived(sum:SellingGeneralAndAdministrativeExpense+ResearchAndDevelopmentExpense)
2,396,800,000USDFY0001099800-24-000004verified
R&D Expense
ResearchAndDevelopmentExpense
903,100,000USDFY0001099800-24-000004verified
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax
5,232,500,000USDFY0001099800-24-000004verified
Stock Buybacks
PaymentsForRepurchaseOfCommonStock
512,800,000USDFY0001099800-24-000004verified
Total Employee Count
TotalEmployees
18,132employeesFY0001099800-24-000032verified